Amdocs Limited Reports First Quarter Fiscal 2026 Results
Rhea-AI Summary
Amdocs (NASDAQ:DOX) reported Q1 FY2026 revenue of $1,156 million, up 4.1% year-over-year (3.5% constant currency). GAAP diluted EPS was $1.45 and non-GAAP diluted EPS was $1.81. Free cash flow was $188 million.
Management closed the Matrixx acquisition for ~$197 million, repurchased $146 million of shares, and increased the quarterly dividend to $0.569 per share. Full-year revenue growth guidance is 1.5%–5.5% as reported and 1.0%–5.0% in constant currency; reiterated free cash flow outlook of $710M–$730M.
Positive
- Revenue of $1,156M, up 4.1% year-over-year
- Non-GAAP diluted EPS of $1.81, above guidance
- Completed Matrixx acquisition for ~$197M
- Free cash flow of $188M and FY26 FCF outlook of $710M–$730M
- Repurchased $146M of shares and raised quarterly dividend to $0.569
Negative
- Full-year revenue growth outlook remains modest at 1.0%–5.0% in constant currency
- GAAP diluted EPS guidance growth narrowed to 10%–17% year-over-year
- Revenue growth is concentrated: managed services ~65% of total revenue
Market Reaction
Following this news, DOX has gained 4.12%, reflecting a moderate positive market reaction. Our momentum scanner has triggered 12 alerts so far, indicating notable trading interest and price volatility. The stock is currently trading at $77.07. This price movement has added approximately $316M to the company's valuation. Trading volume is very high at 3.4x the average, suggesting strong buying interest.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Silver for real-time data.
Key Figures
Market Reality Check
Peers on Argus
DOX fell 1.13% on elevated volume while close peers were mixed: KVYO +1.26%, DBX +0.83%, GTLB +1.23%, INFA +0.08%, and WIX -3.36%. The lack of a consistent direction among peers points to a stock-specific reaction to this earnings report rather than a broad sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 15 | Annual report filing | Neutral | +1.1% | Filed Fiscal 2025 Form 20-F annual report and made it available to investors. |
| Dec 9 | AI partnership win | Positive | +0.2% | e& UAE selected Amdocs’ generative AI platform to integrate GenAI across telco systems. |
| Nov 11 | Product deployment | Positive | -1.8% | Smart launched Amdocs connectX SaaS platform and KiQ app to target Gen Z engagement. |
| Nov 11 | Strategic agreement | Positive | -1.8% | Multi-year deal with Telia Finland to build next-generation digital BSS platform. |
| Nov 11 | OSS modernization deal | Positive | -1.8% | Vivo signed multi-year agreement to modernize operations support systems with Amdocs. |
Recent news has largely involved strategic agreements and AI/telco deployments. Positive partnership announcements on November 11, 2025 coincided with a -1.79% move, suggesting the stock has sometimes sold off or underperformed even on constructive deal news, while regulatory/filing updates have seen modest positive or neutral reactions.
Over the last several months, Amdocs has focused on regulatory filings and telco partnerships. It filed its Fiscal 2025 Form 20‑F and annual report in mid-December 2025, with the stock up about 1.09%. Earlier, it announced a generative AI partnership with e& UAE on December 9, 2025 and multiple digital transformation and OSS modernization agreements with Smart, Telia Finland, and Vivo on November 11, 2025, which coincided with a -1.79% move. Today’s earnings and outlook arrive against this backdrop of ongoing AI-driven and infrastructure-focused deal activity.
Market Pulse Summary
This announcement delivers Q1 2026 revenue of $1,156M, modestly above guidance, with GAAP and non‑GAAP EPS both surpassing prior ranges and free cash flow of $188M. A $4.25B twelve‑month backlog and FY 2026 free cash flow outlook of $710–$730M underscore visibility. At the same time, management guides to relatively moderate 1.5%–5.5% reported revenue growth and continues to invest in AI and the Matrixx acquisition, creating both opportunity and execution risk to track in coming quarters.
Key Terms
non-gaap financial
free cash flow financial
AI-generated analysis. Not financial advice.
Revenue of
T-Mobile USA, Inc. Enters into a Strategic Multi-Year Agreement with Amdocs to Support Its Customer Experience and Operational Excellence Journey
Amdocs Introduces aOS: An Agentic Operating System for Telecommunications
Expects Fiscal 2026 Revenue Growth Outlook of
Reiterates Fiscal 2026 Revenue Growth Outlook of
First Quarter Fiscal 2026 Highlights
(All comparisons are against the prior year)
Revenue of
$1,156 million , up4.1% as reported and up3.5% in constant currency(1); revenue was above the midpoint of the$1,135 -$1,175 million guidance range even with unfavorable foreign currency movements of roughly$3 million compared to our guidance assumptionsRevenue of
$182 million in Europe, up17.1% as compared to last year's first quarterManaged services revenue of
$746 million , equivalent to approximately65% of total revenue and up2.3% as compared to last year's first quarterGAAP diluted EPS of
$1.45 , above the$1.36 -$1.44 guidance range, primarily due to a lower than anticipated GAAP effective tax rateNon-GAAP diluted EPS of
$1.81 , above the guidance range of$1.73 -$1.79 , primarily due to a lower than anticipated non-GAAP effective tax rateGAAP operating income of
$207 million ; GAAP operating margin of17.9% , up 640 basis points sequentially, mainly due to lower restructuring charges, and unchanged compared to last year's first quarterNon-GAAP operating income of
$250 million ; non-GAAP operating margin of21.6% , up 40 basis points as compared to last year's first fiscal quarter and unchanged sequentiallyFree cash flow of
$188 million , comprised of cash flow from operations of$220 million , less$32 million in net capital expenditures(2), including$49 million of restructuring payments; reiterates full year fiscal 2026 free cash outlook of$710 million to$730 million , excluding restructuring paymentsRepurchased
$146 million of ordinary shares during the first fiscal quarterTwelve-month backlog of
$4.25 billion , up approximately$60 million sequentially and up2.7% as compared to last year's first fiscal quarter
(1) Revenue on a constant currency basis assumes exchange rates in the current period were unchanged from the prior period
(2) Please refer to the Selected Financial Metrics tables below (figures may not sum because of rounding)
(3) Expected total shareholder return assumes midpoint of fiscal year 2026 non-GAAP EPS growth outlook, plus dividend yield
JERSEY CITY, NJ / ACCESS Newswire / February 3, 2026 / Amdocs Limited (NASDAQ:DOX), a leading provider of software and services to communications and media companies, today reported operating results for the three months ended December 31, 2025.
"First quarter financial results were consistent with our guidance as we continue to focus on our primary goal of reaccelerating Amdocs' long-term growth and extending our position as a market leader for the generative AI era. I am proud to announce that Amdocs has extended our long-term relationship with T-Mobile under a new multi-year agreement which includes managed services, software development, and AI innovation. In addition, we signed an expanded multi-year engagement at Vodafone Germany, added two new western European logos, and closed the acquisition of Matrixx Software as a strategic consolidation move which complements and expands our activities at Verizon, Telus, Telefonica, Swisscom, Three, Virgin Media O2, Telstra and other customers. As to generative AI, our accelerated development roadmap is progressing as planned with today's announcement of aOS, an agentic operating system purpose-built for telecommunications which we expect can provide a new long-term growth engine for Amdocs," said Shuky Sheffer, president and chief executive officer of Amdocs Management Limited.
"Our first quarter profitability improved significantly from a year ago and was unchanged sequentially as we balanced internal efficiency gains with accelerated generative AI investments. Earnings-to-cash conversion was strong, reflecting consistent execution under the many milestone and outcome-based projects and managed services engagements we are supporting for our customers. Over the busy holiday period, we provided best-in-class mission critical operations support for our customers. We also maintained very high managed services renewal rates, signing expanded multi-year engagements with T-Mobile, Vodafone Germany and other customers which together strengthen our business resiliency, said Tamar Rapaport-Dagim, chief financial officer & chief operating officer of Amdocs Management Limited.
Sheffer concluded, "Across our serviceable addressable market of roughly
Revenue
(All comparisons are against the prior year period)
In millions | ||||||
Three months ended | ||||||
December 31, 2025 | ||||||
Actual | Guidance | |||||
Revenue | ||||||
Revenue Growth, as reported | ||||||
Revenue Growth, constant currency (1) | ||||||
Revenue for the first fiscal quarter of 2026 was slightly above the midpoint of Amdocs' guidance
Revenue for the first fiscal quarter includes a positive impact from foreign currency movements of approximately
$7 million relative to the first quarter of fiscal 2025 and a negative impact from foreign currency movements of approximately$3 million relative to the fourth quarter of fiscal 2025 and compared to our guidance assumptions
Net Income and Earnings Per Share
In thousands, except per share data | ||||||
Three months ended | ||||||
December 31, | ||||||
2025 | 2024 | |||||
GAAP Measures | ||||||
Net Income | ||||||
Net Income attributable to Amdocs Limited | ||||||
Diluted earnings per share | ||||||
Non-GAAP Measures | ||||||
Non-GAAP Net Income | ||||||
Non-GAAP Net Income attributable to Amdocs Limited | ||||||
Non-GAAP Diluted earnings per share | ||||||
Non-GAAP net income excludes amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisition related liabilities measured at fair value, equity-based compensation expenses, restructuring charges, and other, net of related tax effects. For further details of the reconciliation of selected financial metrics from GAAP to Non-GAAP, please refer to the tables below.
Capital Allocation
M&A Activity: On December 23, 2025, Amdocs completed the acquisition of Matrixx, a privately owned company specializing in Charging & Rating solutions for global communication service providers, for a net consideration of approximately
$197 million Quarterly Cash Dividend Program: On February 3, 2026, the Board approved the Company's next quarterly cash dividend payment at the new increased rate of
$0.56 9 per share, as approved at the January 2026 annual general meeting of shareholders and set March 31, 2026 as the record date for determining the shareholders entitled to receive the dividend, which will be payable on April 24, 2026Share Repurchase Activity: Repurchased
$146 million of ordinary shares during the first quarter of fiscal 2026
Twelve-month Backlog
Twelve-month backlog was
Second Quarter Fiscal Year 2026 Outlook | |||
In millions, except per share data | |||
Q2 - 2026 | |||
Revenue | |||
GAAP Diluted earnings per share | |||
Non-GAAP Diluted earnings per share |
Second quarter revenue guidance assumes a positive
$1 million sequential impact from foreign currency fluctuations as compared to the first quarter of fiscal 2026Second quarter non-GAAP diluted EPS guidance excludes primarily equity-based compensation expense of approximately
$0.33 -$0.35 per share, amortization of purchased intangible assets and other acquisition-related costs of approximately$0.15 per share, changes in certain acquisitions related liabilities measured at fair value, and other, net of related tax effectsGAAP diluted EPS guidance does not include the impact of future restructuring charges
Full Year Fiscal 2026 Outlook | ||||||
FY 2026 - Year-over -Year growth | ||||||
Current guidance | Previous guidance | |||||
Revenue Growth, as reported | ||||||
Revenue Growth, constant currency (1) | ||||||
GAAP Diluted earnings per share | ||||||
Non-GAAP Diluted earnings per share | ||||||
FY 2026, in millions | ||||||
Current guidance | Previous guidance | |||||
Free Cash Flow (2) | ||||||
Full year fiscal 2026 revenue guidance incorporates an expected positive impact from foreign currency fluctuations of approximately
0.5% year-over-year compared with a positive impact of0.7% year-over-year previously, and includes some inorganic contribution, including the acquisition of Matrixx Software which was already contemplated in the full year revenue guidanceGAAP diluted EPS guidance does not include the impact of future restructuring charges
Non-GAAP diluted earnings per share growth excludes primarily equity-based compensation expense of approximately
$0.98 -$1.04 per share, amortization of purchased intangible assets and other acquisition-related costs of approximately$0.55 per share, changes in certain acquisitions related liabilities measured at fair value, and other, net of related tax effectsNon-GAAP operating margin is anticipated to be within a range of
21.3% to21.9% for the full year fiscal 2026Non-GAAP operating margin is comprised of GAAP operating margin, excluding amortization of purchased intangible assets and other, equity-based compensation expense, restructuring charges, and changes in certain acquisitions related liabilities measured at fair value
Non-GAAP effective tax rate is anticipated to be within a range of
16% to19% for the full year fiscal 2026Reiterates full year fiscal 2026 free cash flow(2) of
$710 million to$730 million , excluding payments related to restructuring charges; free cash flow(2) is comprised of cash flow from operations, less net capital expenditures
The forward-looking statements regarding our second fiscal quarter 2026 and full year fiscal 2026 guidance take into consideration the Company's current expectations regarding macro and industry specific risks and various uncertainties and certain assumptions that we will discuss on our earnings conference call. However, we note that market dynamics continue to shift rapidly and we cannot predict all possible outcomes, including those resulting from certain geopolitical events, the current inflationary environment, changes to trade policies including tariffs and trade restrictions and the resulting impact on economic activities (as our outlook assumes current economic conditions do not deteriorate significantly due to trade policy or other macro factors), global or regional events, and the prevailing level of macro-economic, business and operational uncertainty, which have created, and continue to create, a significant amount of uncertainty, or from current and potential customer consolidation or their other strategic corporate activities.
Conference Call and Earnings Webcast Presentation Details
Amdocs will host a conference call and earnings webcast presentation on February 3, 2026 at 5:00 p.m. Eastern Time to discuss the Company's first quarter of fiscal 2026 results. To participate in the call, please register here to receive the dial-in numbers and unique access PIN. The conference call and webcast will also be carried live on the Internet and may be accessed via the Amdocs website at https://investors.amdocs.com. Presentation slides will be available shortly before the webcast.
Non-GAAP Financial Measures
This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow(2), revenue on a constant currency(1) basis, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income, non-GAAP net income attributable to Amdocs Limited and non-GAAP diluted earnings per share growth. These other non-GAAP measures exclude the following items:
amortization of purchased intangible assets and other acquisition-related costs;
changes in certain acquisition-related liabilities measured at fair value;
restructuring and unusual charges or benefits;
equity-based compensation expense;
other; and
tax effects related to the above.
Free cash flow(2) equals cash generated by operating activities less net capital expenditures. These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs' results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs' results of operations in conjunction with the corresponding GAAP measures.
Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow(2), revenue on a constant currency(1) basis, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income, non-GAAP net income attributable to Amdocs Limited and non-GAAP diluted earnings per share growth when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.
For its internal budgeting process and in monitoring the results of the business, Amdocs' management uses financial statements that do not include amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisition-related liabilities measured at fair value, restructuring and unusual charges or benefits, equity-based compensation expense, other and related tax effects. Amdocs' management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.
Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of revenue, research and development, selling, general and administrative, operating income, interest and other expenses, net, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.
Supporting Resources
Keep up with Amdocs news by visiting the Company's website
Subscribe to Amdocs' RSS Feed and follow us on Twitter, Facebook, LinkedIn and YouTube
About Amdocs
Amdocs helps the world's leading communications and media companies deliver exceptional customer experiences through reliable, efficient, and secure operations at scale. We provide software products and services that embed intelligence into how work runs across business, IT, and network domains - delivering measurable outcomes in customer experience, network performance, cloud modernization, and revenue growth. With our talented people, and more than 40 years of experience running mission-critical systems around the globe, Amdocs runs billions of transactions daily. Our technology is relied on every day, connecting people worldwide and advancing a more inclusive, connected world. Together, we help those who shape the future to make it amazing. Amdocs is listed on the NASDAQ Global Select Market (NASDAQ:DOX) and reported revenue of
This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs' growth and business results in future quarters and years. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general macroeconomic conditions, prevailing level of macroeconomic, business and operational uncertainty, including as a result of geopolitical events or other regional events or pandemics, changes to trade policies including tariffs and trade restrictions, as well as the current inflationary environment, and the effects of these conditions on the Company's customers' businesses and levels of business activity, including the effect of the current economic uncertainty and industry pressure on the spending decisions of the Company's customers. Amdocs' ability to grow in the business markets that it serves, Amdocs' ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, security incidents, including breaches and cyberattacks to our systems and networks and those of our partners or customers, potential loss of a major customer, our ability to develop long-term relationships with our customers, our ability to successfully and effectively implement artificial intelligence and Generative AI in the Company's offerings and operations, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs' filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2025, filed on December 15, 2025.
Contact:
Matthew Smith
Head of Investor Relations
Amdocs
314-212-8328
E-mail: dox_info@amdocs.com
AMDOCS LIMITED
Consolidated Statements of Income
(In thousands, except per share data)
Three months ended | ||||||||
2025 | 2024 | |||||||
Revenue | $ | 1,155,939 | $ | 1,110,055 | ||||
Operating expenses: | ||||||||
Cost of revenue | 727,723 | 682,259 | ||||||
Research and development | 81,978 | 84,333 | ||||||
Selling, general and administrative | 113,721 | 122,087 | ||||||
Amortization of purchased intangible assets and other | 14,534 | 15,759 | ||||||
Restructuring charges | 11,301 | 6,783 | ||||||
949,257 | 911,221 | |||||||
Operating income | 206,682 | 198,834 | ||||||
Interest and other expense, net | (11,265 | ) | (6,409 | ) | ||||
Income before income taxes | 195,417 | 192,425 | ||||||
Income taxes | 36,963 | 40,573 | ||||||
Net income | $ | 158,454 | $ | 151,852 | ||||
Net income attributable to noncontrolling interests | 888 | 719 | ||||||
Net income attributable to Amdocs Limited | $ | 157,566 | $ | 151,133 | ||||
Basic earnings per share attributable to Amdocs Limited | $ | 1.46 | $ | 1.34 | ||||
Diluted earnings per share attributable to Amdocs Limited | $ | 1.45 | $ | 1.33 | ||||
Cash dividends declared per ordinary share | $ | 0.527 | $ | 0.479 | ||||
Basic weighted average number of shares outstanding | 107,977 | 112,745 | ||||||
Diluted weighted average number of shares outstanding | 108,512 | 113,439 | ||||||
AMDOCS LIMITED
Selected Financial Metrics
(In thousands, except per share data)
Three months ended | ||||||||
2025 | 2024 | |||||||
Revenue | $ | 1,155,939 | $ | 1,110,055 | ||||
Non-GAAP operating income | 249,939 | 235,398 | ||||||
Non-GAAP net income | 197,131 | 188,877 | ||||||
Non-GAAP net income attributable to Amdocs Limited | 196,243 | 188,158 | ||||||
Non-GAAP diluted earnings per share | $ | 1.81 | $ | 1.66 | ||||
Diluted weighted average number of shares outstanding | 108,512 | 113,439 | ||||||
Free Cash Flows
(In thousands)
Three months ended | ||||||||
2025 | 2024 | |||||||
Net Cash Provided by Operating Activities | $ | 220,182 | $ | 105,555 | ||||
Purchase of property and equipment, net (a) | (32,239 | ) | (27,355 | ) | ||||
Free Cash Flow | $ | 187,943 | $ | 78,200 | ||||
(a) The amounts under "Purchase of property and equipment, net", include immaterial proceeds from sale of property and equipment for all periods presented.
AMDOCS LIMITED
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
(In thousands)
Three Months Ended December 31, 2025 | |||||||||||||||||||||||||
GAAP | Amortization of purchased intangible assets and other | Equity based compensation expense | Changes in certain acquisitions related liabilities measured at fair value | Restructuring charges | Other | Tax | Non-GAAP | ||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||||
Cost of revenue | $ | 727,723 | $ | - | $ | (11,373 | ) | $ | (359 | ) | $ | - | $ | - | $ | - | $ | 715,991 | |||||||
Research and development | 81,978 | (1,859 | ) | 80,119 | |||||||||||||||||||||
Selling, general and administrative | 113,721 | (10,858 | ) | 7,027 | 109,890 | ||||||||||||||||||||
Amortization of purchased intangible assets and other | 14,534 | (14,534 | ) | - | |||||||||||||||||||||
Restructuring charges | 11,301 | (11,301 | ) | - | |||||||||||||||||||||
Total operating expenses | 949,257 | (14,534 | ) | (24,090 | ) | 6,668 | (11,301 | ) | - | - | 906,000 | ||||||||||||||
Operating income | 206,682 | 14,534 | 24,090 | (6,668 | ) | 11,301 | - | - | 249,939 | ||||||||||||||||
Interest and other expense, net | (11,265 | ) | 1,573 | (9,692 | ) | ||||||||||||||||||||
Income taxes | 36,963 | 6,153 | 43,116 | ||||||||||||||||||||||
Net income | 158,454 | 14,534 | 24,090 | (6,668 | ) | 11,301 | 1,573 | (6,153 | ) | 197,131 | |||||||||||||||
Net income attributable to noncontrolling interests | 888 | 888 | |||||||||||||||||||||||
Net income attributable to Amdocs Limited | $ | 157,566 | $ | 14,534 | $ | 24,090 | $ | (6,668 | ) | $ | 11,301 | $ | 1,573 | $ | (6,153 | ) | $ | 196,243 | |||||||
Three Months Ended December 31, 2024 | |||||||||||||||||||||||||
GAAP | Amortization of purchased intangible assets and other | Equity based compensation expense | Changes in certain acquisitions related liabilities measured at fair value | Restructuring charges | Other | Tax | Non-GAAP | ||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||||
Cost of revenue | $ | 682,259 | $ | - | $ | (13,250 | ) | $ | - | $ | - | $ | - | $ | - | $ | 669,009 | ||||||||
Research and development | 84,333 | (2,271 | ) | 82,062 | |||||||||||||||||||||
Selling, general and administrative | 122,087 | (10,999 | ) | 12,498 | 123,586 | ||||||||||||||||||||
Amortization of purchased intangible assets and other | 15,759 | (15,759 | ) | - | |||||||||||||||||||||
Restructuring charges | 6,783 | (6,783 | ) | - | |||||||||||||||||||||
Total operating expenses | 911,221 | (15,759 | ) | (26,520 | ) | 12,498 | (6,783 | ) | - | - | 874,657 | ||||||||||||||
Operating income | 198,834 | 15,759 | 26,520 | (12,498 | ) | 6,783 | - | - | 235,398 | ||||||||||||||||
Interest and other expense, net | (6,409 | ) | 6,048 | (361 | ) | ||||||||||||||||||||
Income taxes | 40,573 | 5,587 | 46,160 | ||||||||||||||||||||||
Net income | 151,852 | 15,759 | 26,520 | (12,498 | ) | 6,783 | 6,048 | (5,587 | ) | 188,877 | |||||||||||||||
Net income attributable to noncontrolling interests | 719 | 719 | |||||||||||||||||||||||
Net income attributable to Amdocs Limited | $ | 151,133 | $ | 15,759 | $ | 26,520 | $ | (12,498 | ) | $ | 6,783 | $ | 6,048 | $ | (5,587 | ) | $ | 188,158 | |||||||
AMDOCS LIMITED
Condensed Consolidated Balance Sheets
(In thousands)
As of | ||||||||
December 31, | September 30, | |||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 247,875 | $ | 324,999 | ||||
Accounts receivable, net, including unbilled | 962,780 | 935,751 | ||||||
Prepaid expenses and other current assets | 333,224 | 331,387 | ||||||
Total current assets | 1,543,879 | 1,592,137 | ||||||
Property and equipment, net | 744,706 | 768,557 | ||||||
Lease assets | 179,081 | 182,088 | ||||||
Goodwill and other intangible assets, net | 3,247,622 | 3,046,962 | ||||||
Other noncurrent assets | 628,794 | 660,086 | ||||||
Total assets | $ | 6,344,082 | $ | 6,249,830 | ||||
LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||
Current liabilities | ||||||||
Accounts payable, accruals and other | $ | 1,167,772 | $ | 1,201,206 | ||||
Short-term financing arrangements | 130,000 | - | ||||||
Lease liabilities | 37,808 | 38,725 | ||||||
Deferred revenue | 125,209 | 118,861 | ||||||
Total current liabilities | 1,460,789 | 1,358,792 | ||||||
Lease liabilities | 137,495 | 140,776 | ||||||
Long-term debt, net of unamortized debt issuance costs | 647,058 | 646,901 | ||||||
Other noncurrent liabilities | 633,620 | 632,681 | ||||||
Total Amdocs Limited Shareholders' equity | 3,423,005 | 3,429,453 | ||||||
Noncontrolling interests | 42,115 | 41,227 | ||||||
Total equity | 3,465,120 | 3,470,680 | ||||||
Total liabilities and equity | $ | 6,344,082 | $ | 6,249,830 | ||||
AMDOCS LIMITED
Consolidated Statements of Cash Flows
(In thousands)
Three months ended | ||||||||
2025 | 2024 | |||||||
Cash Flow from Operating Activities: | ||||||||
Net income | $ | 158,454 | $ | 151,852 | ||||
Reconciliation of net income to net cash provided by operating activities: | ||||||||
Depreciation, amortization and impairment | 50,736 | 46,968 | ||||||
Amortization of debt issuance cost | 157 | 151 | ||||||
Equity-based compensation expense | 24,090 | 26,520 | ||||||
Deferred income taxes | 15,152 | 1,651 | ||||||
Loss from short-term interest-bearing investments | - | 662 | ||||||
Net changes in operating assets and liabilities, net of amounts acquired: | ||||||||
Accounts receivable, net | (14,547 | ) | 2,417 | |||||
Prepaid expenses and other current assets | 18,816 | (14,787 | ) | |||||
Other noncurrent assets | 17,597 | (7,925 | ) | |||||
Lease assets and liabilities, net | (1,190 | ) | (2,329 | ) | ||||
Accounts payable, accrued expenses and accrued personnel | (19,383 | ) | (50,837 | ) | ||||
Deferred revenue | 6,516 | 867 | ||||||
Income taxes payable, net | (9,327 | ) | (5,129 | ) | ||||
Other noncurrent liabilities | (26,889 | ) | (44,526 | ) | ||||
Net cash provided by operating activities | $ | 220,182 | $ | 105,555 | ||||
Cash Flow from Investing Activities: | ||||||||
Purchase of property and equipment, net (a) | (32,239 | ) | (27,355 | ) | ||||
Proceeds from sale of short-term interest-bearing investments | - | 33,362 | ||||||
Net cash paid for business acquisitions | (194,489 | ) | (57,083 | ) | ||||
Net Cash from equity investments and other | 1,846 | 16,347 | ||||||
Net cash used in investing activities | $ | (224,882 | ) | $ | (34,729 | ) | ||
Cash Flow from Financing Activities: | ||||||||
Repurchase of shares | (146,168 | ) | (144,483 | ) | ||||
Proceeds from employee stock option exercises | 1,700 | 4,408 | ||||||
Payments of dividends | (57,156 | ) | (54,081 | ) | ||||
Distribution to noncontrolling interests | - | (1,323 | ) | |||||
Borrowings under financing arrangements | 130,000 | - | ||||||
Payment of contingent consideration and deferred payment of business acquisitions | (800 | ) | (7,599 | ) | ||||
Net cash used in financing activities | $ | (72,424 | ) | $ | (203,078 | ) | ||
Net decrease in cash and cash equivalents | (77,124 | ) | (132,252 | ) | ||||
Cash and cash equivalents at beginning of period | 324,999 | 346,085 | ||||||
Cash and cash equivalents at end of period | $ | 247,875 | $ | 213,833 | ||||
AMDOCS LIMITED
Supplementary Information
(In millions)
Three months ended | ||||||||||||||||||||
December 31, | September 30, | June 30, | March 31, | December 31, | ||||||||||||||||
2025 | 2025 | 2025 | 2025 | 2024 | ||||||||||||||||
North America | $ | 764.7 | $ | 762.4 | $ | 745.4 | $ | 738.3 | $ | 737.4 | ||||||||||
Europe | 181.7 | 179.8 | 189.4 | 180.7 | 155.2 | |||||||||||||||
Rest of the World | 209.5 | 208.0 | 209.6 | 209.2 | 217.4 | |||||||||||||||
Total Revenue | $ | 1,155.9 | $ | 1,150.2 | $ | 1,144.4 | $ | 1,128.2 | $ | 1,110.1 | ||||||||||
Three months ended | ||||||||||||||||||||
December 31, | September 30, | June 30, | March 31, | December 31, | ||||||||||||||||
2025 | 2025 | 2025 | 2025 | 2024 | ||||||||||||||||
Managed Services Revenue | $ | 745.9 | $ | 748.3 | $ | 771.5 | $ | 747.1 | $ | 728.9 | ||||||||||
as of | ||||||||||||||||||||
December 31, | September 30, | June 30, | March 31, | December 31, | ||||||||||||||||
2025 | 2025 | 2025 | 2025 | 2024 | ||||||||||||||||
12-Month Backlog | $ | 4,250 | $ | 4,190 | $ | 4,150 | $ | 4,170 | $ | 4,140 | ||||||||||
SOURCE: Amdocs - IR
View the original press release on ACCESS Newswire
FAQ
What were Amdocs (DOX) Q1 FY2026 results for revenue and EPS?
How does Amdocs' FY2026 revenue guidance affect DOX shareholders?
What material acquisitions or capital actions did Amdocs announce in Q1 FY2026 (DOX)?
How significant is managed services revenue for Amdocs (DOX)?
What is Amdocs' free cash flow outlook and recent cash performance (DOX)?
What customer and product developments did Amdocs highlight in Q1 FY2026 (DOX)?
